Public record of meeting, 17June 2019
Meeting of 17 June, 2019–18 June, 2019
Li Ka Shing Knowledge Institute, Toronto, ON
PRESENT
Task Force Members
- Brett Thombs (Chair)
- Ainsley Moore (Vice-Chair)
- Brett Thombs
- Ainsley Moore
- Heather Colquhoun
- Stéphane Groulx
- Michael Kidd
- Scott Klarenbach
- Eddy Lang (Day 2)
- John LeBlanc
- Navindra Persaud
- Donna Reynolds
- John Riva
- Guylène Thériault
- Brenda Wilson (Day 1)
Task Force Administrators
- Daniela Cortinovis
- Katie Elder
PHAC
- Rachel Rodin
- Marc Avey
- Susan Courage
- Eva Graham
- Heather Limburg
- Bradley Mitchelmore
- Kate Morissette
- Rob Stirling
- Laure Tessier
- Gregory Traversy
GHGD
- Rachel Rodin
- Eva Graham
- Heather Limburg (via teleconference)
- Bradley Mitchelmore
- Kate Morissette
- Rob Stirling
- Laure Tessier
- Gregory Traversy
- Ismat Kanga (via teleconference)
- Melissa Subnath (via teleconference)
- Susan Courage (via teleconference)
- Alejandra Jaramillo Garcia (via teleconference)
Edmonton ERSC
- Jennifer Pillay
- Lisa Hartling
- Aireen Wingert (via teleconference)
Ottawa ERSC
- Andrew Beck
- Mona Hersi (via teleconference)
- Julian Little
- David Moher(Day 2)
JGH
- Daniela Cortinovis
- Katie Elder
- Sharon Straus
- Kathleen Einarson
- Shusmita Rashid
- David Flaherty
- Lynsey Burnett
- Clara Narcisse-Merveille
Interns (via teleconference)
- Geneviève Cadieux
- Amanda Ramydal
- Amanda Tzenov
Communications
- Kim Barnhardt
Guests
- Ahmed Abou-Setta
Regrets: Marc Avey (GHGD), Roland Grad (Task Force), Christina Korownyk (Task Force), Chantal Plante (GHGD), John Riva (Task Force), Evangeline Seganathy (Interns), Mark Shew (Interns), Adrienne Stevens (ERSC)
MINUTES
Day 1
1. Welcome and Introductions – Brett Thombs
Dr. Thombs welcomed the group to Toronto and thanked meeting participants for their attendance. Dr. Thombs asked everyone to introduce themselves. He then reviewed logistical items and expense forms, which will be sent out after the meeting.
Dr. Thombs noted recent accomplishments in the work of the Task Force.
2. Hypertension – Brenda Wilson
Dr. Wilson led an update on behalf of the Hypertension Working Group, with a focus on the guideline’s proposed Key Questions.
3. Chlamydia & Gonorrhea – Ainsley Moore
Dr. Moore led an update on behalf of the Chlamydia & Gonorrhea Working Group, seeking Task Force input on the draft Evidence-to-Decision (EtD) framework.
4. Topics Selection – Ainsley Moore
Dr. Moore led an update on final topic selection for 2019-2020. The main goal of the conversation was to discuss ratings and comments, and to narrow the selection of topics for scoping and guideline development.
5. Polypharmacy – Nav Persaud
Dr. Persaud provided an update on behalf of the Polypharmacy Working Group and presented a proposal to the full Task Force to revise the guideline’s target population and to clarify the terminology of the guideline’s topic.
6. Knowledge Translation (KT) Team Update – Knowledge Translation Team
The KT staff led an update on behalf of the Knowledge Translation (KT) team, reviewing completed KT activities and those currently underway or upcoming.
7. Prioritization of Recommendations from 2018 TF Annual Evaluation Report – Lynsey Burnett, Kate Einarson
On behalf of the KT team, Ms. Burnett and Dr. Einarson led a prioritization exercise on recommendations from the 2018 Annual Evaluation.
8. Cervical Cancer Update – Donna Reynolds
Dr. Reynolds provided a scoping update on behalf of the Cervical Cancer Working Group.
Day 2
9. GHGD Timeline Update – Bradley Mitchelmore
Dr. Mitchelmore reviewed the timelines for product deliverables from the Global Health and Guidelines Division (GHGD).
10. Depression (Pregnancy/postpartum) – Eddy Lang
Dr. Lang reviewed draft recommendation statements for the guideline on depression in pregnant and postpartum populations, seeking Task Force input.
11. Depression in Adults – Eddy Lang
Dr. Lang presented the draft Evidence-to-Decision (EtD) framework, including the draft recommendation statement.
12. Verbal Updates – Brett Thombs, John LeBlanc, Stéphane Groulx, Greg Traversy, Guylène Thériault
Dr. Thombs reported on recent devlopments in the Thyroid Dysfunction Working Group, while Dr. LeBlanc led a verbal update on behalf of the Depression in Children & Adolescents Working Group. Dr. Groulx also updated the Task Force on behalf of the Esophageal Cancer Working Group, and Mr. Traversy reviewed progress in the Tobacco Cessation Working Group. Lastly, Dr. Thériault reported on activity in the Fragility Fractures Working Group.
13. Publication of Stakeholder Statements and COIs – Brett Thombs
Dr. Thombs invited Task Force input on a proposal to publish stakeholder statements and COI declarations.
14. Transparent Topics Selection – Brett Thombs
Dr. Thombs invited Task Force input on a proposal related to dissemination of information on the Task Force topics selection process.
15. Methods Update – Greg Traversy
Mr. Traversy provided an update on behalf of the Methods Working Group, reviewing recent steps toward implementing GIN principles in COI management within the Task Force.
16. Communications Update – Kim Barnhardt
Ms. Barnhardt provided an update on the broader communications strategy for the Task Force.
17. Falls Prevention – John Riva
Dr. Riva provided an update on behalf of the Falls Prevention Working Group, reviewing background information and progress on scoping to-date.
18. Next Steps and Adjournment – Ainsley Moore
Dr. Moore thanked the group for their attendance. She reminded the Task Force to please send expense materials to the Task Force administrators soon. Dates for the next meeting are October 28th and 29th, 2019, and the location is again Saint Michael’s Hospital in Toronto.
She reminded the group that an email would be sent out soon regarding expense forms. Please save receipts and original boarding passes for reimbursement. Feedback on venue and logistics of the meeting is welcome.